Status:
RECRUITING
FCHV-HTN Implementation Trial in Nepal
Lead Sponsor:
Yale University
Collaborating Sponsors:
Dhulikhel Hospital
Institute for Implementation Science and Health
Conditions:
Hypertension
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
The goal of this hybrid type III study incorporating a cluster-randomized trial is to assess the effect of a community health worker-led hypertension prevention and control program (CHPC) on the imple...
Detailed Description
INTRODUCTION: Hypertension (HTN) is a global public health challenge. About 13.5% of global total mortality is attributed to high blood pressure (BP) worldwide. In addition, about 54% of strokes and ...
Eligibility Criteria
Inclusion
- High blood pressure (BP) of 140/90 mmHg or higher.
Exclusion
- Severe illness requiring bed rest
- Pregnant women, due to their special health needs
Key Trial Info
Start Date :
December 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2028
Estimated Enrollment :
3572 Patients enrolled
Trial Details
Trial ID
NCT06081010
Start Date
December 2 2024
End Date
August 31 2028
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhulikhel Hospital
Dhulikhel, Nepal